| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Current standard values of health utility scores for evaluating cost-effectiveness in liver disease: A meta-analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tomohiro Ishinuki, Shigenori Ota, Kohei Harada, Masaki Kawamoto, Makoto Meguro, Goro Kutomi, Hiroomi Tatsumi, Keisuke Harada, Koji Miyanishi, Toru Kato, Toshio Ohyanagi, Thomas T Hui and Toru Mizuguchi |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Grants-in-Aid from JSPS KAKENHI |
JP 20K10404 (to Mizuguchi T) |
| Grants-in-Aid from JSPS KAKENHI |
JP 21K10715 (to Ishinuki T) |
| the Hokkaido Hepatitis B Litigation Orange Fund |
2059198 (to Mizuguchi T) |
| the Hokkaido Hepatitis B Litigation Orange Fund |
2136589 (to Harada K) |
| Terumo Life Science Foundation |
2000666 |
| Pfizer Health Research Foundation |
2000777 |
| Viral Hepatitis Research Foundation of Japan |
3039838 |
| Project Mirai Cancer Research Grants |
202110251 |
| Takahashi Industrial and Economic Research Foundation |
12-003-106 |
| Daiichi Sankyo Company |
2109540 |
| Shionogi and Co. |
2109493 |
| MSD |
2099412 |
| Takeda Pharmaceutical Company |
2000555 |
| Sapporo Doto Hospital |
2039118 |
| Noguchi Hospital |
2029083 |
| Doki-kai Tomakomai Hospital |
2059203 |
| Tsuchida Hospital |
2000092 |
| Shinyu-kai Noguchi Hospital |
2029083 (to Mizuguchi T) |
| the Yasuda Medical Foundation |
28-1 (to Ishinuki T) |
|
| Corresponding Author |
Toru Mizuguchi, MD, PhD, Professor, Department of Nursing, Surgical Sciences, Sapporo Medical University, S1, W17, Chuo-ku, Sapporo 0608556, Japan. tmizu@sapmed.ac.jp |
| Key Words |
Quality of life; EuroQOL 5-dimensions 5-levels; Short from-36; RAND-36; Health Utilities Index-Mark |
| Core Tip |
This study summarized current knowledge about health utility assessments, including the EuroQOL 5-dimensions 5-levels (EQ-5D-5L), EuroQol-visual analogue scale, short from-36, RAND-36, and Health Utilities Index-Mark2/Mark3. The EQ-5D-5L is the most popular questionnaire for health utility assessments. Health utility assessments need to be used widely and routinely. |
| Publish Date |
2022-08-16 11:59 |
| Citation |
Ishinuki T, Ota S, Harada K, Kawamoto M, Meguro M, Kutomi G, Tatsumi H, Harada K, Miyanishi K, Kato T, Ohyanagi T, Hui TT, Mizuguchi T. Current standard values of health utility scores for evaluating cost-effectiveness in liver disease: A meta-analysis. World J Gastroenterol 2022;28(31): 4442-4455 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i31/4442.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i31.4442 |
